Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 226 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

30/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

30 / 100

Complexity

20 / 100

Risk factors

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the active substances Zidovudin and Lamivudin (ATC J05AR01) for the German market.
  • Participation in a non-exclusive open house discount agreement scheme.
Show full summary

Open house model for non-exclusive discount agreements on pharmaceuticals with active substances Zidovudin and Lamivudin (ATC J05AR01). The AOK Rheinland-Pfalz/Saarland invites all interested pharmaceutical companies to conclude uniform discount contracts without a competitive award procedure. Contracts run for a maximum of 24 months from June 2025, with rolling entry possible at the start of each month. The buyer may replace these agreements with exclusive contracts via tenders. No estimated value or award criteria are specified. This is not a public procurement under EU directive 2014/24.

Risks

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Pharmaceutical products must be authorized and marketable in Germany.
  • Proof of marketability via Lauer-Taxe listing or AMIce database extract.

Administrative

  • Submission of signed contract documents before each desired start date.

Buyer

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

Non-exclusive discount agreements for pharmaceuticals containing Zidovudin and Lamivudin. Uniform terms for all participants. All licensed pharmaceutical companies with marketable products in Germany can join. Contracts start at the earliest on 01.06.2025 and end at the latest on 31.05.2027. Rolling entry possible on the 1st of each month with submission by end of the month preceding the desired start month.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
237769-2025

Documents (1)

Similar tenders